Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Facet Joints; Degeneration: early-phase trial registry
2 of 2 indexed Facet Joints; Degeneration trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Facet Joints; Degeneration: 2 US clinical trials tracked, 2 recruiting.
Facet Joints; Degeneration is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Alimorad Farshchian, running 1 of these trials.
Enrollment posture brief
Registry condition facet-joints-degeneration
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Facet Joints; Degeneration lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Facet Joints; Degeneration on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Facet Joints; Degeneration is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
Brigham and Women's Hospital
NCT01788410
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
Alimorad Farshchian
NCT05909709
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Facet Joints; Degeneration records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Facet Joints; Degeneration trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Facet Joints; Degeneration page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Facet Joints; Degeneration trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Alimorad Farshchian sponsors the most Facet Joints; Degeneration trials on record, review their full trial history before evaluating a specific study. See Alimorad Farshchian's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Facet Joints; Degeneration condition card totals 2 registered trials; most-linked intervention MRI Seednet Cryotherapy System (Galil Medical); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.